SUMMARY We report 2 contrasting cases of a seronegative polyarthritis associated with angioimmunoblastic lymphadenopathy (AILD). Both cases were nonerosive, with symmetrical involvement of the elbows, wrists, knees, and ankles. In one the arthritis appeared concurrently with the main systemic manifestations of AILD. The second presented with polyarthritis 18 months before the onset of AILD. This patient received azathioprine for 11 months before developing AILD, which raises the possibility of this drug being the causative agent.
Angioimmunoblastic lymphadenopathy (AILD) is a recently described lymphoproliferative disorder of unknown aetiology and pathogenesis. 13 The typical clinical features are lymphadenopathy, hepatosplenomegaly, rash, and hypergammaglobulinaemia.
Both arthralgia and arthritis have also been described in 18 cases4'-3 and appear to be less common but definite clinical features.
In most of the reported cases rheumatic features have not been well described. In some cases arthralgia alone has been mentioned,4'I" but in 11 cases arthritis has been a feature. 13 Five cases have been documented as being seronegative4 7-913 and 3 as being seropositive.4 6 10 Two of the seropositive patients appeared to have had coexistent rheumatoid arthritis. In one case12 with bilateral carpal tunnel syndrome and polyarthropathy, synovial histology was obtained which showed a mononuclear infiltrate.
We describe 2 contrasting cases. In the first case the arthritis appeared with the main systemic manifestations of AILD, while in the second case the arthritis preceded the onset of AILD by 18 months.
Case reports CASE 
1
A 50-year-old Caucasian woman presented in August 1980 with a one-week history of fever, sore throat, swollen glands, and an itchy rash over her arms and trunk, which later spread to involve her palms, lower legs, feet, and face.
Her symptoms continued, and in early September she was admitted to hospital following the onset of a Acepted for publication 7 A regimen of mustine, vinblastine, procarbazine, and prednisolone at 6-week intervals was begun. After 6 cycles she went into clinical remission, with regression of her lymphadenopathy, hepatosplenomegaly, and arthritis, and this has been maintained to date (August 1982 
